Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 21873440)

1.

Safety of serial MRI in patients with implantable cardioverter defibrillators.

Junttila MJ, Fishman JE, Lopera GA, Pattany PM, Velazquez DL, Williams AR, Trachtenberg BH, Sanina C, Mather J, Hare JM.

Heart. 2011 Nov;97(22):1852-6. doi: 10.1136/heartjnl-2011-300153. Epub 2011 Aug 26.

2.

Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.

Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, Litt H, Schwab JO, Schild H, Sommer T.

J Am Coll Cardiol. 2009 Aug 4;54(6):549-55. doi: 10.1016/j.jacc.2009.04.050.

3.

A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).

Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C.

J Interv Card Electrophysiol. 2010 Jun;28(1):59-66. doi: 10.1007/s10840-009-9463-y. Epub 2010 Jan 29.

PMID:
20111895
4.

Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.

Cohen JD, Costa HS, Russo RJ.

Am J Cardiol. 2012 Dec 1;110(11):1631-6. doi: 10.1016/j.amjcard.2012.07.030. Epub 2012 Aug 23.

PMID:
22921995
5.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

6.

Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.

Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, Auricchio A, Priori S, Sommer T.

Europace. 2008 Mar;10(3):336-46. doi: 10.1093/europace/eun021. Review.

7.

Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator.

Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR.

Pacing Clin Electrophysiol. 2005 Apr;28(4):336-8.

PMID:
15826272
8.

Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs).

Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL.

Pacing Clin Electrophysiol. 2005 Apr;28(4):270-3.

PMID:
15826257
9.

Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T.

Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR.

Circulation. 2004 Aug 3;110(5):475-82. Epub 2004 Jul 26.

10.

Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly.

Halshtok O, Goitein O, Abu Sham'a R, Granit H, Glikson M, Konen E.

Isr Med Assoc J. 2010 Jul;12(7):391-5.

11.

Magnetic resonance of the heart in a muscular dystrophy patient with an MR conditional ICD: assessment of safety, diagnostic value and technical limitations.

Florian A, Ludwig A, Rösch S, Sechtem U, Yilmaz A.

J Cardiovasc Magn Reson. 2013 Jun 11;15:49. doi: 10.1186/1532-429X-15-49.

12.

[Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].

Al-Sabagh KH, Christensen BE, Thøgersen AM, Petersen HH, Videbaek R, Pehrson S, Chen X, Thomsen C, Svendsen JH.

Ugeskr Laeger. 2010 Jun 7;172(23):1740-4. Danish.

PMID:
20534201
13.

Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T.

Naehle CP, Kreuz J, Strach K, Schwab JO, Pingel S, Luechinger R, Fimmers R, Schild H, Thomas D.

Am Heart J. 2011 Jun;161(6):1096-105. doi: 10.1016/j.ahj.2011.03.007. Epub 2011 May 11.

PMID:
21641356
14.

Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices.

Buendía F, Cano Ó, Sánchez-Gómez JM, Igual B, Osca J, Sancho-Tello MJ, Olagüe J, Salvador A.

Europace. 2011 Apr;13(4):533-8. doi: 10.1093/europace/euq501. Epub 2011 Jan 11.

15.

Patient alert in implantable cardioverter defibrillators: toy or tool?

Becker R, Ruf-Richter J, Senges-Becker JC, Bauer A, Weretka S, Voss F, Katus HA, Schoels W.

J Am Coll Cardiol. 2004 Jul 7;44(1):95-8.

16.

Is magnetic resonance safe in implanted cardiac devices patients?

Cernuschi G, Cringoli M; Gruppo di Autoformazione Metodologica (GrAM).

Intern Emerg Med. 2012 Jun;7(3):281-2. doi: 10.1007/s11739-012-0780-2. Epub 2012 Apr 11.

PMID:
22492008
17.

Reuse of explanted, resterilized implantable cardioverter-defibrillators: a cohort study.

Pavri BB, Lokhandwala Y, Kulkarni GV, Shah M, Kantharia BK, Mascarenhas DA.

Ann Intern Med. 2012 Oct 16;157(8):542-8. doi: 10.7326/0003-4819-157-8-201210160-00004.

PMID:
23070487
18.

Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators.

Sasaki T, Hansford R, Zviman MM, Kolandaivelu A, Bluemke DA, Berger RD, Calkins H, Halperin HR, Nazarian S.

Circ Cardiovasc Imaging. 2011 Nov;4(6):662-70. doi: 10.1161/CIRCIMAGING.111.965764. Epub 2011 Sep 23.

19.

Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.

Awad K, Griffin J, Crawford TC, Lane Cox S, Ferrick K, Mazur A, Pena RE, Lloyd SG, Michalski J, Johnson W, Bailey WM.

Heart Rhythm. 2015 Jun 3. pii: S1547-5271(15)00692-X. doi: 10.1016/j.hrthm.2015.06.002. [Epub ahead of print]

PMID:
26049048
20.

A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.

Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR.

Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk